Medicine and Dentistry
Anti-Epidermal Growth Factor Receptor
9%
Cancer Therapy
9%
Cell Proliferation
9%
Cell Surface
18%
Cetuximab
9%
down Regulation
100%
Epidermal Growth Factor Receptor
100%
Epitope
9%
Immunoglobulin Fragment
9%
In Vitro
18%
Internalization
27%
Ligand
9%
Ligand Binding
9%
Liposome
100%
Lysosome
9%
Monoclonal Antibody
9%
Nanobody
100%
Neoplasm
9%
Polyethylene Glycol
9%
Receptor
72%
Receptor Antagonist
9%
Receptor down Regulation
27%
Single Chain Fragment Variable Antibody
9%
Tumor Cell
9%
Pharmacology, Toxicology and Pharmaceutical Science
Antigen
9%
Cell Proliferation
9%
Cetuximab
9%
Epidermal Growth Factor Receptor
100%
Epitope
9%
Immunoglobulin Fragment
9%
Ligand
18%
Liposome
100%
Monoclonal Antibody
9%
Mouse
9%
Nanobody
100%
Neoplasm
27%
Receptor
90%
Receptor Antagonist
9%
Single Chain Fragment Variable Antibody
9%
Immunology and Microbiology
Binding Antibody
9%
Cell Proliferation
9%
Cell Surface
18%
Cetuximab
9%
Degradation
27%
down Regulation
100%
Epidermal Growth Factor
100%
Epitope
9%
Immunoglobulin Fragment
9%
Internalization
27%
Ligand Binding
9%
Lysosome
9%
Monoclonal Antibodies
9%
Mouse
9%
Receptor down Regulation
27%
Single-Chain Variable Fragment
9%
Single-Domain Antibody
100%
Tumor Cell
9%